Skip to main content
Skip to secondary navigation
Stanford University
(link is external)
Search this site
Submit Search
Menu
People
Training & Education
Undergraduate Programs
Entrepreneurship
Application Information
Entrepreneurship Mentors
Funded Projects
Graduate Student Programs
Chemistry/Biology Interface
SIGF Affiliated with ChEM-H
Postdoc Programs
Seed Grants
Funded Projects
Postdoc Society
Retreat
Research
Institute Scholars
Nucleus
Medicinal Chemistry
High-Throughput Screening
Macromolecular Structure
CryoEM
Metabolomics
Protein Engineering
Research Areas
Innovative Medicines Accelerator (IMA)
Microbiome Therapies (MITI)
News & Events
News
Institute Scholars
Students and postdocs
Nucleus
Awards
IMA
ChEM-H funded projects
Events
Opportunities
Funding Opportunities
Using chemoproteomics to develop new cancer therapeutics
2024 Sarafan ChEM-H Seed Grant
Faculty Recruitment
Careers
Giving
About
What is ChEM-H?
Who is ChEM-H?
Institute Scholars
Faculty Fellows
Postdoctoral Scholars
Graduate Students
Undergraduate Scholars
Why is diversity our mission?
Benefactor
10-Year Report
Contact Us
Andrew Hinman
Nucleus Scientists
Associate Director, Medicinal Chemistry, Innovative Medicines Accelerator (IMA)
Contact
hinman@stanford.edu
Mail Code
5085
View Full Stanford Profile
Back to Top
